Boardroom Alpha
Boardroom Alpha
THC · Additional Proxy Materials (DEFA14A) · Filed April 16, 2026

Tenet Healthcare Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 16, 2026
Ticker
THC
Accession
0001193125-26-159125
Boardroom Alpha · Filing insights

Tenet Healthcare's board urges votes FOR all director nominees and FOR advisory executive compensation and Deloitte auditor ratification.

About Tenet Healthcare Corp
Market cap
$14.1B
1Y TSR
+10.1%
3Y TSR
+34.2%
Board grade
B+
Sector
Healthcare
CEO
Saumya Sutaria
Last annual meeting: May 27, 2026 · View full Tenet Healthcare Corp profile →
DEFA14A
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No. )

 

 

Filed by the Registrant        Filed by a Party other than the Registrant 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under Rule 14a-12

Tenet Healthcare Corporation

(Name of Registrant as Specified in Its Charter)

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 
 


LOGO

 

C/O TABULATOR, P.O. BOX 8016, CARY, NC 27512-9903

 

LOGO

   LOGO
 

 

LOGO

 

  

 

Proxy Materials: Notice of Annual Meeting & Proxy

Statement and Annual Report on Form 10-K

 

Important Notice Regarding the Availability of Proxy Materials for the Shareholders Meeting to be held on May 27, 2026 for Shareholders of record as of April 2, 2026.

 

 

Tenet Healthcare Corporation

 

Annual Meeting of Shareholders

Wednesday, May 27, 2026 at 9:00 AM, Central Time

 

Annual Meeting to be held live via the Internet - please visit www.proxydocs.com/THC for more details.

 

You must register to attend, participate and/or vote at the annual meeting at

www.proxydocs.com/THC.

 

 

For a convenient way to view proxy materials, VOTE and obtain directions to attend the meeting go to www.proxydocs.com/THC.

 

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

 

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

  

To order paper materials, use one of the following methods:

 

LOGO

 

Internet:

www.investorelections.com/THC

 

 

LOGO

 

Call:

1-866-648-8133

Under U.S. Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the Internet.

 

If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before May 22, 2026.

  

 

LOGO

 

Email:

paper@investorelections.com

 

* If requesting materials by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR inquiries should be included with your e-mail requesting materials.

 

LOGO

     

 

Have the 12 digit control number located in the box above available when you access the website and follow the instructions.

SEE REVERSE FOR FULL AGENDA

Copyright © 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved


LOGO

 

  

Tenet Healthcare Corporation Annual Meeting of  Shareholders

  

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

FOR EACH OF THE DIRECTOR NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSALS 2 AND 3

 

   PROPOSAL
1.    Election of Directors
  
   1.01 Saumya Sutaria
  
   1.02 J. Robert Kerrey
  
   1.03 Vineeta Agarwala
  
   1.04 James L. Bierman
  
   1.05 Roy Blunt
  
   1.06 Richard W. Fisher
  
   1.07 Meghan M. FitzGerald
  
   1.08 Cecil D. Haney
  
   1.09 Christopher S. Lynch
  
   1.10 Richard J. Mark
  
   1.11 Tammy Romo
  
   1.12 Nadja Y. West
  
2.    To approve, on an advisory basis, the Company’s executive compensation.
  
3.    To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2026.
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Tenet Healthcare Corp (THC)

Reference

Frequently asked questions

When did Tenet Healthcare Corp file this DEFA14A?
Tenet Healthcare Corp (THC) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 16, 2026. The accession number assigned by EDGAR is 0001193125-26-159125.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Tenet Healthcare's board urges votes FOR all director nominees and FOR advisory executive compensation and Deloitte auditor ratification. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Tenet Healthcare Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Tenet Healthcare Corp has filed under CIK 70318, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer